• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

    1.680 UNCHANGED
    Streaming Delayed Price Updated: 2:20 PM EDT, Mar 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 654,756
    Open 1.720
    Bid (Size) 1.670 (1,800)
    Ask (Size) 1.680 (1,200)
    Prev. Close 1.680
    Today's Range 1.660 - 1.770
    52wk Range 1.300 - 2.979
    Shares Outstanding 210,356,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Inovio Stock Up On Earnings, Pipeline Progress ↗
    Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher on Friday morning after the company reported fourth-quarter results. 
    Via Benzinga
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Performance

    YTD
    -0.6%
    -0.6%
    1 Month
    -0.6%
    -0.6%
    3 Month
    -21.1%
    -21.1%
    6 Month
    -36.6%
    -36.6%
    1 Year
    -18.0%
    -18.0%

    More News

    Read More
    News headline image
    INO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Inovio and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    ROSEN, A LEADING LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    UPCOMING DEADLINE: Inovio Pharmaceuticals (INO) Securities Fraud Class Action – April 7, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Is Inovio Pharmaceuticals Stock Going to $0? ↗
    Via The Motley Fool
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Deadline Approaching: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    INO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Law Offices of Frank R. Cruz Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders to Inquire About Securities Fraud Class Action
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire

    Frequently Asked Questions

    Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?
    Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market
    What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?
    The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.680
    When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 03/13/26 02:20 PM ET
    What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 353.40M
    How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?
    Inovio Pharmaceuticals, Inc. - Common Stock has 353M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.